Beauty Health (NASDAQ:SKIN) Upgraded at Zacks Research

Zacks Research upgraded shares of Beauty Health (NASDAQ:SKIN) from a hold rating to a strong-buy rating in a research report released on Tuesday morning,Zacks.com reports.

Other analysts also recently issued reports about the company. Cowen restated a “hold” rating on shares of Beauty Health in a research note on Monday, September 22nd. Roth Capital started coverage on Beauty Health in a research note on Friday, September 19th. They set a “buy” rating and a $3.50 price objective for the company. TD Cowen raised their price objective on Beauty Health from $2.00 to $2.50 and gave the company a “hold” rating in a research note on Monday, September 22nd. Stifel Nicolaus raised their price target on shares of Beauty Health from $3.00 to $4.00 and gave the stock a “hold” rating in a research report on Friday, August 1st. Finally, Wall Street Zen raised shares of Beauty Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $2.81.

Beauty Health Price Performance

Shares of SKIN stock opened at $1.30 on Tuesday. The company has a market capitalization of $164.87 million, a PE ratio of -4.64 and a beta of 1.21. The firm has a fifty day simple moving average of $1.96 and a 200-day simple moving average of $1.71. The company has a current ratio of 5.15, a quick ratio of 4.15 and a debt-to-equity ratio of 4.91. Beauty Health has a twelve month low of $0.78 and a twelve month high of $2.69.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The business had revenue of $78.20 million during the quarter, compared to analyst estimates of $74.67 million. Beauty Health had a negative net margin of 6.13% and a negative return on equity of 32.82%. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts anticipate that Beauty Health will post -0.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. ProShare Advisors LLC boosted its holdings in shares of Beauty Health by 45.5% in the 2nd quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock valued at $45,000 after buying an additional 7,336 shares during the period. Simplicity Wealth LLC acquired a new position in Beauty Health in the second quarter valued at approximately $49,000. AQR Capital Management LLC acquired a new position in Beauty Health in the first quarter valued at approximately $40,000. Police & Firemen s Retirement System of New Jersey boosted its stake in Beauty Health by 87.5% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company’s stock valued at $60,000 after acquiring an additional 14,653 shares during the period. Finally, Kapitalo Investimentos Ltda acquired a new position in Beauty Health in the second quarter valued at approximately $60,000. 93.26% of the stock is owned by institutional investors and hedge funds.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.